HURA

TuHURA BiosciencesB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

25%

Probability

Target price

$2.87

Analysis reference price unavailable

Analysis 2025-11-17 · RankAlpha Sentiment AI

Most likely

Base case

55%

Probability

Target price

$2.26

Analysis reference price unavailable

Analysis 2025-11-17 · RankAlpha Sentiment AI

B-

Bear case

20%

Probability

Target price

$1.44

Analysis reference price unavailable

Analysis 2025-11-17 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2025-11-17

AI commentary

Market interest appears muted with thin liquidity and limited public coverage; the official recent close anchor underscores a low-volume microcap profile [#RA-2025-11-14]. Investor focus is likely binary (clinical/financing events), so sentiment swings quickly on news [#RA-2025-11-14]. Coverage and filings visibility remain limited, increasing volatility for any headline [#RA-2025-11-14].

RankAlpha Sentiment AI - 2025-11-17

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

-eventCash-runway / financing update (public disclosure)High impact

Any disclosure of cash runway or a financing plan (dilution vs runway clarity) typically moves small biotech names; market likely reacts within days of a release [#RA-2025-11-14].

-catalystDownside from equity financing / dilutionHigh impact

High probability of dilutive financing for microcap biotech with limited cash could cause sharp share-price declines if large issuance occurs [#RA-2025-11-14].

-catalystClinical-stage program progression / trial startHigh impact

Initiation or positive early results in a clinical program could re-rate the microcap; currently low visibility and limited coverage [#RA-2025-11-14].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-11-17 • Updated nightlySource: Internal modelMethodology